According to Rodman & Renshaw, Pfizer's (NYSE: PFE) recent license agreement with Coley Pharmaceutical could indicated big pharma is also ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE